European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) was established in 1993. Inaugurated in Lisbon in 1995, it is one of the EU’s decentralised agencies. The EMCDDA exists to provide the EU and its Member States with a factual overview of European drug problems and a solid evidence base to support the drugs debate. Today it offers policymakers the data they need for drawing up informed drug laws and strategies. It also helps professionals and practitioners working in the field pinpoint best practice and new areas of research.

Mission

The EMCDDA was set up to provide 'factual, objective, reliable and comparable information concerning drugs, drug addiction and their consequences'

EMCDDA best practice portal

Website
EMCDDA's best practice portal is designed to help you find practical and reliable information on what works (and what doesn’t) in the areas of prevention, treatment, harm reduction and social reintegration. It will help you identify tried...

Cannabis control approaches across Europe

Video and audio recordings
The second webinar in EMCDDA's cannabis webinar series focuses on the debate around cannabis control approaches across Europe. It will aim to clarify concepts such as depenalisation, decriminalisation and legalisation. Background: Cannabis...

Policy and practice briefings: Workplaces

Book
 - 
EMCDDA has published Policy and practice briefings in Workplaces. This policy and practice briefing provides an overview of the key issues, response options, evidence and implications for policy and practice. It summarises the available...

Synthetic cannabinoids in Europe – a review

Book
 - 
This report provides a technical review of the current body of knowledge regarding synthetic cannabinoids that are monitored by the the EU Early Warning System. The aim of this report is to strengthen situational awareness of synthetic...